Sustaining HIV, hepatitis and STIs services amid declining health aid

The global health responses to HIV, hepatitis, sexually transmitted infections and other communicable diseases – such as malaria, tuberculosis, vaccine preventable diseases and neglected tropical diseases – have been severely impacted by the recent suspensions and reductions in official development assistance for health.

Over 20 million people are at risk of losing access to life-saving HIV medications, while critical health services are facing major disruptions. These interruptions threaten the continuity of essential health services, leading to setbacks in preventing new infections and increasing the risk of a resurgence in epidemics, potentially reversing decades of progress.

This page provides links to key data and updates on reported disruptions in health service delivery, as well as technical resources, guidance and recommendations to help countries, ministries of health and communities sustain the provision of essential services during this challenging period.

It also offers practical information for communities and most vulnerable people on managing potential treatment interruptions due to service disruptions, drug shortages or stockouts.

Our collective efforts focus on ensuring the continuity of care, minimizing setbacks and working toward sustainable, long-term solutions to protect the health of vulnerable populations.